Clinical Trials Directory

Trials / Completed

CompletedNCT05311800

High-Intensity Interval Training and Fat Mass Losses

Effect of Two Isoenergetic Modes of High-Intensity Interval Training on Total and Abdominal Fat Mass Loss in Men With Overweight or Obesity.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aims of this study was to compare two isoenergetic HIIT (High-intensity Interval training) programs (cycling vs. running) on body composition, substrate oxidation at rest and during a moderate exercise, muscle functionality, glycaemic control, lipid profile, inflammation, maximal aerobic capacity (VO2max) and gut microbiota composition in men with overweight or obesity. The investigators hypothesized that both programs could decrease total, abdominal and visceral fat mass but due to differences in muscle solicitation, metabolism adaptation and blood flow, and that running could favors greater fat mass losses.

Detailed description

The first aim of this study was to compare two isoenergetic HIIT programs (cycling vs. running) on body composition in men with overweight or obesity. 20 men with overweight or obesity should completed HIIT program three times a week during twelve weeks. i) High intensity interval training - BIKE (HIIE BIKE) 10 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (37min30s) ii) High intensity interval training - RUN (HIIE RUN) 9 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (35min15s) Body composition will be measured before and after HIIT program by Dual-energy X-ray absorptiometry (DXA).

Conditions

Interventions

TypeNameDescription
OTHERPhysical activityComparison of HIIT mode (running vs cycling)

Timeline

Start date
2021-09-01
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2022-04-05
Last updated
2023-02-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05311800. Inclusion in this directory is not an endorsement.